Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:50 PM
Ignite Modification Date:
2025-12-24 @ 7:50 PM
NCT ID:
NCT04858204
Eligibility Criteria:
Inclusion Criteria:
* advanced NSCLC (stage IIIB-IV)
* failure of at least one line of chemotherapy.
* age ≥18 years,
* initiation of nivolumab between 01/09/2015 and 30/09/2016.
Exclusion Criteria:
* nivolumab initiation after October 2016
* prior involvement in an immunotherapy trial
* refusal to participate.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04858204
Study Brief:
Protocol Section:
NCT04858204